1161976-13-1 Usage
Description
5-(Tributylstannyl)isoquinoline is a chemical compound characterized by an isoquinoline ring structure with a tributylstannyl functional group attached at the fifth position. This tributylstannyl group, which consists of three butyl groups bonded to a tin atom, provides a reactive site for further chemical reactions. Its unique molecular structure and reactivity make 5-(Tributylstannyl)isoquinoline a versatile building block in organic synthesis, particularly for the development of complex organic molecules, pharmaceuticals, and agrochemicals.
Uses
Used in Organic Synthesis:
5-(Tributylstannyl)isoquinoline is used as a building block for the creation of more complex organic molecules due to its reactive tributylstannyl group and isoquinoline ring structure. This allows for the synthesis of a wide range of chemical compounds with diverse properties and applications.
Used in Pharmaceutical Industry:
5-(Tributylstannyl)isoquinoline is used as a key intermediate in the production of pharmaceuticals. Its reactivity and molecular structure enable the development of new drugs with specific therapeutic properties, contributing to the advancement of medicine and healthcare.
Used in Agrochemical Industry:
5-(Tributylstannyl)isoquinoline is employed as a precursor in the synthesis of agrochemicals, such as pesticides and herbicides. Its unique chemical properties allow for the creation of effective and targeted agrochemicals that can improve crop protection and yield.
Check Digit Verification of cas no
The CAS Registry Mumber 1161976-13-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,6,1,9,7 and 6 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1161976-13:
(9*1)+(8*1)+(7*6)+(6*1)+(5*9)+(4*7)+(3*6)+(2*1)+(1*3)=161
161 % 10 = 1
So 1161976-13-1 is a valid CAS Registry Number.
1161976-13-1Relevant articles and documents
ANGIOGENESIS INHIBITORS
-
Page/Page column 70-71, (2010/11/05)
Compounds of Structural Formula I or pharmaceutically acceptable salts thereof, are effective inhibitors of angiogenesis:
